Daniel Arber to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Daniel Arber has written about Antineoplastic Combined Chemotherapy Protocols.
Connection Strength
0.261
-
De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with =30% blasts in older adults: a Bone Marrow Pathology Group study. Am J Hematol. 2014 Nov; 89(11):E193-9.
Score: 0.057
-
Acute myeloid leukemia, version 2.2013. J Natl Compr Canc Netw. 2013 Sep 01; 11(9):1047-55.
Score: 0.054
-
Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333.
Score: 0.028
-
Interleukin-2 after autologous stem-cell transplantation for adult patients with acute myeloid leukemia in first complete remission. J Clin Oncol. 2003 Feb 15; 21(4):615-23.
Score: 0.026
-
CD20-Positive peripheral T-cell lymphoma: report of a case after nodular sclerosis Hodgkin's disease and review of the literature. Mod Pathol. 2000 Nov; 13(11):1244-52.
Score: 0.022
-
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. Leukemia. 2000 Jul; 14(7):1191-6.
Score: 0.021
-
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study. Haematologica. 2014 May; 99(5):821-9.
Score: 0.014
-
Lymphoma in pregnancy initially diagnosed as vaginal intraepithelial neoplasia and lichen planus. Obstet Gynecol. 2011 Aug; 118(2 Pt 2):486-489.
Score: 0.012
-
Fluorescence in situ hybridization investigation of cutaneous lesions in acute promyelocytic leukemia. Mod Pathol. 2005 Dec; 18(12):1569-76.
Score: 0.008
-
Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides. J Clin Oncol. 2005 Sep 01; 23(25):6163-71.
Score: 0.008
-
Recurrent B-cell neoplasms after Rituximab therapy: an immunophenotypic and genotypic study. Leuk Lymphoma. 2002 Dec; 43(12):2335-41.
Score: 0.006
-
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000 Mar 01; 95(5):1588-93.
Score: 0.005